全文获取类型
收费全文 | 23224篇 |
免费 | 1466篇 |
国内免费 | 322篇 |
专业分类
耳鼻咽喉 | 143篇 |
儿科学 | 897篇 |
妇产科学 | 238篇 |
基础医学 | 1539篇 |
口腔科学 | 132篇 |
临床医学 | 4395篇 |
内科学 | 3961篇 |
皮肤病学 | 139篇 |
神经病学 | 2160篇 |
特种医学 | 1339篇 |
外国民族医学 | 1篇 |
外科学 | 3206篇 |
综合类 | 2686篇 |
一般理论 | 1篇 |
预防医学 | 1169篇 |
眼科学 | 543篇 |
药学 | 1432篇 |
16篇 | |
中国医学 | 326篇 |
肿瘤学 | 689篇 |
出版年
2023年 | 369篇 |
2022年 | 579篇 |
2021年 | 837篇 |
2020年 | 913篇 |
2019年 | 808篇 |
2018年 | 791篇 |
2017年 | 833篇 |
2016年 | 770篇 |
2015年 | 763篇 |
2014年 | 1641篇 |
2013年 | 1580篇 |
2012年 | 1309篇 |
2011年 | 1398篇 |
2010年 | 1142篇 |
2009年 | 1146篇 |
2008年 | 1097篇 |
2007年 | 984篇 |
2006年 | 909篇 |
2005年 | 790篇 |
2004年 | 645篇 |
2003年 | 572篇 |
2002年 | 485篇 |
2001年 | 452篇 |
2000年 | 353篇 |
1999年 | 268篇 |
1998年 | 259篇 |
1997年 | 272篇 |
1996年 | 222篇 |
1995年 | 244篇 |
1994年 | 205篇 |
1993年 | 205篇 |
1992年 | 208篇 |
1991年 | 158篇 |
1990年 | 150篇 |
1989年 | 118篇 |
1988年 | 149篇 |
1987年 | 116篇 |
1986年 | 105篇 |
1985年 | 164篇 |
1984年 | 135篇 |
1983年 | 106篇 |
1982年 | 124篇 |
1981年 | 107篇 |
1980年 | 113篇 |
1979年 | 72篇 |
1978年 | 66篇 |
1977年 | 62篇 |
1976年 | 69篇 |
1975年 | 41篇 |
1974年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
1.
2.
3.
BackgroundCentrally located pancreatic lesions are often treated with extended pancreaticoduodenectomy or distal pancreatectomy resulting in loss of healthy parenchyma and a high risk of diabetes and exocrine insufficiency. Robotic central pancreatectomy (RCP) is a parenchyma sparring alternative that has been shown safe and feasible [[1], [2]].MethodsIn this article, we describe our operative technique and the perioperative outcomes of a series of RCP for low-grade or benign pancreatic tumors.ResultsSix patients (5 female and 1 man) with a median age of 51.5 (44–68) years underwent a RCP for 2 serous cystadenomas, 2 mucinous cystic tumors, 1 neuroendocrine tumor, and 1 autoimmune pancreatitis. There were no conversions, intraoperative complications, or perioperative transfusions. Median operative time and was 240 (230–291) minutes and median blood loss was 100 (100–400) ml. The median hospital stay was 8 (5–27) days. There were no mortalities, reoperations, or readmissions. One patient developed a grade B pancreatic fistula which was successfully managed conservatively. All resections had free margins and the median tumor size was 2.5 (1.5–3.5) cm. After a mean follow-up of 46 months, no patients presented new-onset diabetes or exocrine insufficiency.ConclusionsRCP represents the least invasive option for both the patient and the pancreatic parenchyma. With a standardized technique, RCP results in low postoperative morbidity and excellent long-term pancreatic function. Although our results are excellent, POPF still represents the main complication of central pancreatectomy with an incidence ranging from 0 to 80% depending on multiple factors such as the surgeon, technique, and pancreatic texture. 相似文献
4.
《Journal of emergency nursing》2022,48(4):484-491
BackgroundCalcium chloride is commonly used in emergency departments in the treatment of a variety of emergencies. Historically, administration via central venous catheters has been preferred owing to its high osmolarity and vesicant properties. Although preferred, central access may not always be available in time-sensitive, emergent situations leading to many instances of peripheral administration. The objective of this analysis was to evaluate the charted safety of peripheral venous administration of 10% calcium chloride.MethodsA single-center retrospective chart review was performed in patients who received 10% calcium chloride in the adult emergency department evaluating for the incidence of infusion-related adverse events. Patients were excluded if they were less than 18 years of age or had a lack of catheter documentation during 10% calcium chloride administration or if the 10% calcium chloride was documented as given through a central venous catheter.ResultsA total of 72 administrations were evaluated. Patients were predominantly male (67%), with a median age of 55 years and body mass index of 29.2. The primary outcome demonstrated that 4 infusion-related adverse events occurred (6%) with grade 1 (n = 1) and grade 0 (n = 3) documented incidence of infusion-related adverse events. None of the documented incidence of infusion-related adverse events resulted in permanent tissue injury, and all patients had conservative management.DiscussionThis study demonstrated that administration of 10% calcium chloride via peripheral venous catheters may be feasible and seemed to carry a low incidence of documented complications. Further prospective studies are needed to confirm study observations. 相似文献
5.
6.
7.
眼静脉空气栓塞(OVAE)是玻璃体切割手术中一种罕见的致命并发症。因手术部位靠近心脏且位于心脏上方,OVAE可能是所有手术中引起静脉空气栓塞(VAE)最严重的。随着玻璃体切割手术的发展,免缝合状态的灌注套管可出现向外滑动,使得灌注气体进入脉络膜上腔,导致涡静脉撕裂。玻璃体腔气体灌注时,外伤及脉络膜黑色素瘤手术导致的脉络膜血管伤口暴露于气体中,这使得加压气体可能通过撕裂的涡静脉或异常的脉络膜静脉开口进入循环系统导致OVAE。目前OVAE的定义、发病机制、临床表现及防治措施在不断完善,但多数玻璃体视网膜外科医生和麻醉医师仍不了解该医源性并发症。提高对OVAE的认识将有助于早期发现该并发症,进而做出及时处理,同时制定有效的预防策略。通过临床和实验室研究相结合,可不断优化OVAE防治原则。充分认识OVAE的发病机理和临床特点,关注 OVAE继发性病变的特征以及重视多学科间的合作有助于OVAE应急处理和预防措施的建立和完善。 相似文献
8.
《Journal of vascular and interventional radiology : JVIR》2022,33(4):445-450
PurposeTo evaluate the effectiveness and safety of fluoroscopy-guided percutaneous high ligation (FPHL) combined with fluoroscopy-guided foam sclerotherapy (FGFS) to treat varicose veins of the great saphenous veins (GSVs).Materials and MethodsThis was a retrospective study of 113 patients (mean age, 62.1 ± 10.8 years; 60 men) with varicose veins of the GSVs (133 limbs) that were treated with FPHL combined with FGFS between April 1 and October 31, 2019. Demographic and clinical data were collected from these patients before the FPHL procedure, after which FGFS was performed. The preterminal GSV was ligated percutaneously by a percutaneously-positioned polypropylene ligature under fluoroscopic guidance. The outcome of ligation was confirmed by venography. Then, foam sclerotherapy was performed under fluoroscopy. At 1-year follow-up, GSV occlusion was evaluated by ultrasound. The venous clinical severity scores (VCSSs) were compared between the preoperative and 1-year follow-up periods.ResultsThe technical success rate was 100% (133 limbs). Complete 12-month follow-up was available for 112 limbs (84.2%) and 103 of these limbs (92.0%) remained occluded during this period. The VCSS improved from 4.71 ± 2.15 to 0.74 ± 0.60 (V = 6328, P < .001). During follow-up, there were 16 limbs with thrombophlebitis and 38 limbs with saphenous junction pain; these events were alleviated within 2 weeks of the procedure. There was no deep venous thrombosis or other severe adverse events.ConclusionsFPHL combined with FGFS to treat varicose veins in the GSVs achieved an occlusion rate of 92% and improved the clinical symptoms within 1 year; this minimally-invasive procedure was safe and effective. 相似文献
9.
《Journal of thoracic oncology》2022,17(1):116-129
IntroductionManagement of central nervous system (CNS) metastases in patients with driver-mutated NSCLC has traditionally incorporated both tyrosine kinase inhibitors (TKIs) and intracranial radiation. Whether next generation, CNS-penetrant TKIs can be used alone without upfront radiation, however, remains unknown. This multi-institutional retrospective analysis aimed to compare outcomes in patients with EGFR- or ALK-positive NSCLC who received CNS-penetrant TKI therapy alone versus in combination with radiation for new or progressing intracranial metastases.MethodsData were retrospectively collected from three academic institutions. Two treatment groups (CNS-penetrant TKI alone versus TKI + CNS radiation therapy) were compared for both EGFR- and ALK-positive cohorts. Outcome variables included time to progression, time to intracranial progression, and time to treatment failure, measured from the date of initiation of CNS-penetrant TKI therapy.ResultsA total of 147 patients were included (EGFR n = 94, ALK n = 52, both n = 1). In patients receiving radiation, larger metastases, neurologic symptoms, and receipt of steroids were more common. There were no significant differences between TKI and CNS radiation therapy plus TKI groups for any of the study outcomes, including time to progression (8.5 versus 6.9 mo, p = 0.13 [EFGR] and 11.4 versus 13.4 mo, p = 0.98 [ALK]), time to intracranial progression (14.8 versus 20.5 mo, p = 0.51 [EGFR] and 18.1 versus 21.8 mo, p = 0.65 [ALK]), or time to treatment failure (13.8 versus 8.6 mo, p = 0.26 [EGFR] and 13.5 versus 23.2 mo, p = 0.95 [ALK]).ConclusionsThese results provide preliminary evidence that intracranial activity of CNS-penetrant TKIs may enable local radiation to be deferred in appropriately selected patients without negatively affecting progression. 相似文献
10.
目的 探讨145例弥漫性大B细胞淋巴瘤(DLBCL)患者静脉血栓栓塞(VTE)发生率及危险因素。方法 选取2016年5月-2019年8月收治的DLBCL患者145例,依据深静脉血栓超声诊断结果分为VTE组(22例)和无VTE组(123例)。采用多因素logistic回归分析DLBCL患者发生VTE的危险因素,及两组复发率、无复发生存率、总体生存率差异。结果 静脉置管、34个疗程化疗未完全缓解(non-CR)、D-二聚体≥1.44 μg/ml是VTE的独立危险因素(OR=5.143、9.000、16.514,P<0.05),体能评分(PS评分) ≥2分为保护因素(OR=0.170,P<0.05);两组复发率、无复发生存率、总体生存率比较差异无统计学意义(P>0.05)。结论 静脉置管、34个疗程化疗non-CR、D-二聚体≥1.44 μg/ml均为DLBCL患者发生VTE的独立危险因素,PS评分≥2分为保护因素。 相似文献